201 related articles for article (PubMed ID: 16189093)
1. Resistance to antimicrobial peptides and stress response in Mycoplasma pulmonis.
Fehri LF; Sirand-Pugnet P; Gourgues G; Jan G; Wróblewski H; Blanchard A
Antimicrob Agents Chemother; 2005 Oct; 49(10):4154-65. PubMed ID: 16189093
[TBL] [Abstract][Full Text] [Related]
2. Activities of antimicrobial peptides and synergy with enrofloxacin against Mycoplasma pulmonis.
Fassi Fehri L; Wróblewski H; Blanchard A
Antimicrob Agents Chemother; 2007 Feb; 51(2):468-74. PubMed ID: 17101680
[TBL] [Abstract][Full Text] [Related]
3. Biofilms protect Mycoplasma pulmonis cells from lytic effects of complement and gramicidin.
Simmons WL; Dybvig K
Infect Immun; 2007 Aug; 75(8):3696-9. PubMed ID: 17517864
[TBL] [Abstract][Full Text] [Related]
4. Interaction of cationic antimicrobial peptides with Mycoplasma pulmonis.
Park HJ; Kang KM; Dybvig K; Lee BL; Jung YW; Lee IH
FEBS Lett; 2013 Oct; 587(20):3321-6. PubMed ID: 23994526
[TBL] [Abstract][Full Text] [Related]
5. Characterization of antimicrobial activity against Listeria and cytotoxicity of native melittin and its mutant variants.
Wu X; Singh AK; Wu X; Lyu Y; Bhunia AK; Narsimhan G
Colloids Surf B Biointerfaces; 2016 Jul; 143():194-205. PubMed ID: 27011349
[TBL] [Abstract][Full Text] [Related]
6. Interactions between Mycoplasma pulmonis and immune systems in the mealworm beetle, Tenebrio molitor.
Lim S; Yun HK; Kang KM; Lee BL; Won R; Lee IH
Insect Biochem Mol Biol; 2019 Nov; 114():103231. PubMed ID: 31479697
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial Peptide Exposure Selects for Resistant and Fit Stenotrophomonas maltophilia Mutants That Show Cross-Resistance to Antibiotics.
Blanco P; Hjort K; Martínez JL; Andersson DI
mSphere; 2020 Sep; 5(5):. PubMed ID: 32999081
[TBL] [Abstract][Full Text] [Related]
8. Resistance of Mycoplasma pulmonis to complement lysis is dependent on the number of Vsa tandem repeats: shield hypothesis.
Simmons WL; Denison AM; Dybvig K
Infect Immun; 2004 Dec; 72(12):6846-51. PubMed ID: 15557605
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial efficacy of Cecropin A (1-7)- Melittin and Lactoferricin (17-30) against multi-drug resistant Salmonella Enteritidis.
Gourkhede DP; Bhoomika S; Pathak R; Yadav JP; Nishanth D; Vergis J; Malik SVS; Barbuddhe SB; Rawool DB
Microb Pathog; 2020 Oct; 147():104405. PubMed ID: 32707313
[TBL] [Abstract][Full Text] [Related]
10. Scorpion Venom Antimicrobial Peptides Induce Siderophore Biosynthesis and Oxidative Stress Responses in Escherichia coli.
Tawfik MM; Bertelsen M; Abdel-Rahman MA; Strong PN; Miller K
mSphere; 2021 May; 6(3):. PubMed ID: 33980680
[TBL] [Abstract][Full Text] [Related]
11. Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: molecular basis for the differential mechanisms of action.
Saugar JM; Rodríguez-Hernández MJ; de la Torre BG; Pachón-Ibañez ME; Fernández-Reyes M; Andreu D; Pachón J; Rivas L
Antimicrob Agents Chemother; 2006 Apr; 50(4):1251-6. PubMed ID: 16569836
[TBL] [Abstract][Full Text] [Related]
12. Hemolytic Activity of Antimicrobial Peptides.
Oddo A; Hansen PR
Methods Mol Biol; 2017; 1548():427-435. PubMed ID: 28013523
[TBL] [Abstract][Full Text] [Related]
13. Activities of synthetic peptides against human pathogenic bacteria.
Bogucka K; Królicka A; Kamysz W; Ossowski T; Lukasiak J; Lojkowska E
Pol J Microbiol; 2004; 53(1):41-4. PubMed ID: 15330266
[TBL] [Abstract][Full Text] [Related]
14. Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii.
Rodríguez-Hernández MJ; Saugar J; Docobo-Pérez F; de la Torre BG; Pachón-Ibáñez ME; García-Curiel A; Fernández-Cuenca F; Andreu D; Rivas L; Pachón J
J Antimicrob Chemother; 2006 Jul; 58(1):95-100. PubMed ID: 16636085
[TBL] [Abstract][Full Text] [Related]
15. Genomic Signatures of Experimental Adaptation to Antimicrobial Peptides in Staphylococcus aureus.
Johnston PR; Dobson AJ; Rolff J
G3 (Bethesda); 2016 Jun; 6(6):1535-9. PubMed ID: 27172179
[TBL] [Abstract][Full Text] [Related]
16. Comparative activities of cecropin A, melittin, and cecropin A-melittin peptide CA(1-7)M(2-9)NH2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii.
Giacometti A; Cirioni O; Kamysz W; D'Amato G; Silvestri C; Del Prete MS; Łukasiak J; Scalise G
Peptides; 2003 Sep; 24(9):1315-8. PubMed ID: 14706545
[TBL] [Abstract][Full Text] [Related]
17. Damage of the bacterial cell envelope by antimicrobial peptides gramicidin S and PGLa as revealed by transmission and scanning electron microscopy.
Hartmann M; Berditsch M; Hawecker J; Ardakani MF; Gerthsen D; Ulrich AS
Antimicrob Agents Chemother; 2010 Aug; 54(8):3132-42. PubMed ID: 20530225
[TBL] [Abstract][Full Text] [Related]
18. Ceragenins and Antimicrobial Peptides Kill Bacteria through Distinct Mechanisms.
Mitchell G; Silvis MR; Talkington KC; Budzik JM; Dodd CE; Paluba JM; Oki EA; Trotta KL; Licht DJ; Jimenez-Morales D; Chou S; Savage PB; Gross CA; Marletta MA; Cox JS
mBio; 2022 Feb; 13(1):e0272621. PubMed ID: 35073755
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic antimicrobial peptides may compromise natural immunity.
Habets MG; Brockhurst MA
Biol Lett; 2012 Jun; 8(3):416-8. PubMed ID: 22279153
[TBL] [Abstract][Full Text] [Related]
20. A D-enantiomer of the antimicrobial peptide GL13K evades antimicrobial resistance in the Gram positive bacteria Enterococcus faecalis and Streptococcus gordonii.
Hirt H; Hall JW; Larson E; Gorr SU
PLoS One; 2018; 13(3):e0194900. PubMed ID: 29566082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
